ENTRY       D09959                      Drug
NAME        Ruxolitinib (USAN/INN)
FORMULA     C17H18N6
EXACT_MASS  306.1593
MOL_WEIGHT  306.365
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG02020  JAK inhibitor
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: D11AH09 L01EJ01
            Chemical structure group: DG00719
            Product (DG00719): D09960<JP/US>
EFFICACY    Antineoplastic, Janus kinase (JAK) inhibitor
TARGET      JAK1 [HSA:3716] [KO:K11217]
            JAK2 [HSA:3717] [KO:K04447]
  PATHWAY   hsa04062(3717)  Chemokine signaling pathway
            hsa04630(3716+3717)  JAK-STAT signaling pathway
            hsa05200(3716+3717)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576]; CYP2C9 [HSA:1559]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AH Agents for dermatitis, excluding corticosteroids
                 D11AH09 Ruxolitinib
                  D09959  Ruxolitinib (USAN/INN)
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EJ Janus-associated kinase (JAK) inhibitors
                 L01EJ01 Ruxolitinib
                  D09959  Ruxolitinib (USAN/INN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG00719  Ruxolitinib
                 D09959  Ruxolitinib
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00719  Ruxolitinib
                D09959  Ruxolitinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00719  Ruxolitinib
                 D09959  Ruxolitinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               JAK family
                JAK1
                 D09959  Ruxolitinib (USAN/INN)
                JAK2
                 D09959  Ruxolitinib (USAN/INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09959
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG00719  Ruxolitinib
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00719  Ruxolitinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00719  Ruxolitinib
DBLINKS     CAS: 941678-49-5
            PubChem: 135626684
            ChEBI: 66919
            PDB-CCD: RXT
            LigandBox: D09959
ATOM        23
            1   C8x C    19.8100  -17.0100
            2   N5x N    19.8100  -18.4100
            3   C8y C    21.0000  -19.1100
            4   C8y C    22.2600  -18.4100
            5   C8y C    22.2600  -17.0100
            6   N5x N    21.0000  -16.3100
            7   C8x C    23.5900  -18.8300
            8   C8x C    24.3600  -17.7100
            9   N4x N    23.5900  -16.5900
            10  C8y C    21.0000  -20.5100
            11  C8x C    19.8800  -21.3500
            12  N4y N    20.3000  -22.6800
            13  N5x N    21.7000  -22.6800
            14  C8x C    22.1900  -21.3500
            15  C1b C    17.9200  -22.6800
            16  C1c C    19.1100  -23.3800
            17  C1y C    19.1100  -24.7800
            18  C3b C    17.9314  -21.2800
            19  N3a N    17.9314  -19.8800
            20  C1x C    17.9774  -25.6029
            21  C1x C    18.4100  -26.9344
            22  C1x C    19.8100  -26.9344
            23  C1x C    20.2426  -25.6029
BOND        26
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    3  10 1
            12   10  11 2
            13   11  12 1
            14   12  13 1
            15   13  14 2
            16   10  14 1
            17   15  16 1
            18   16  12 1
            19   16  17 1 #Up
            20   15  18 1
            21   18  19 3
            22   17  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   17  23 1
///
